Day: January 31, 2022

• Dr. Zojwalla brings extensive and diverse experience in clinical development and regulatory strategy for novel oncology therapies • As part of planned leadership transition, former CMO Pamela Klein, M.D., will become a senior advisor and member of Olema’s Scientific Advisory Board SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) —  Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced the appointment of Naseem Zojwalla, M.D., as Chief Medical Officer. Bringing more than 15 years of oncology and clinical development experience across the biopharmaceutical industry and academia, Dr. Zojwalla joins Olema as the company prepares to advance its lead therapeutic...

Palmetto GBA Covers Medicare Patients in Seven States BURLINGTON, Mass. and JERUSALEM, Jan. 31, 2022 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that a final Local Coverage Determination (LCD) has been published providing coverage applicable to the BrainsWay Deep TMS™ system for the treatment of obsessive-compulsive disorder (OCD). The final LCD was issued by the Medicare Administrative Contractor (MAC) Palmetto GBA, which covers Medicare patients in Alabama, Georgia, North Carolina, South Carolina, Tennessee, Virginia, and West Virginia, representing over 9 million covered lives. The final LCD was published following a formal meeting hosted by Palmetto last year and a...

Portfolio Yield for the three months ended December 31, 2021 increased to 27.7% compared to 27.3% during the prior year third quarter Originations year-over-year on new Contracts purchased for the three months ended December 31, 2021 increased by 27.4% compared to prior year third quarter Originations year-over-year on Direct Loans for the three months ended December 31, 2021 increased by 84.7% compared to prior year third quarter Accounts 60+ days delinquent decreased to 3.5%, excluding Chapter 13 bankruptcy accounts, compared to 3.9% as of the prior year third quarterCLEARWATER, Fla., Jan. 31, 2022 (GLOBE NEWSWIRE) — Nicholas Financial, Inc. (NASDAQ: NICK) announced a net loss for the three months ended December 31, 2021 of $0.7 million compared to net income of $3.8 million for the three months ended December 31, 2020. As...

Figure 1Joshua Vein long-section view showing the FR-DD-21-175 intersection and other key intersections that lie along the proposed ‘dilation zone’ trend.Figure 2Joshua Vein long-section view showing three proposed ‘dilation zone’ trends that dip between 24-30 degrees.Figure 3Split section of drill core from hole FR-DD-21-175, part of a sample grading 30.1 g/t Au, 107 g/t Ag.TORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) announces continued success at intercepting high-grade gold from its ongoing 4,000-metre drilling program at the Omagh Project in Northern Ireland. Hole FR-DD-21-175 was drilled from surface and targeted the Joshua Vein. It intersected 17.4 grams per tonne (g/t) gold (Au),...

CINCINNATI, Jan. 31, 2022 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that, as a result of the filing of its annual financial statements and management discussion & analysis for the financial years ended September 30, 2021 and 2020, and the CEO and CFO certificates, on January 27, 2022, the management cease trade order issued by the British Columbia Securities Commission (“BCSC”) on December 30, 2021 has been revoked by the BCSC effective January 28, 2022. ABOUT QUIPT HOME MEDICAL CORP. The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market....

SEE REZOLVE VIDEO HERE:  https://vimeo.com/669906793 LONDON, Jan. 31, 2022 (GLOBE NEWSWIRE) — Rezolve, a leader in mobile commerce and engagement, today announced the expansion of its board of directors with the addition of two new members, Dr. Stephen Perry and Dr. Derek Smith, who add depth and experience in the areas of payments and e-commerce. On December 17, 2021, Rezolve announced that it had entered into a definitive business combination agreement with Armada Acquisition Corp. I (NASDAQ: AACI), a publicly traded special purpose acquisition company. Upon closing of the transaction, the combined company’s shares are expected to trade on the NASDAQ under the ticker symbol “ZONE”. “We are pleased to welcome Perry and Smith to the board,” said Dan Wagner, Rezolve’s chairman and CEO. “Their expertise in devising and implementing...

SAULT STE. MARIE, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, announced today that the Company will release its fiscal 2022 third quarter financial results after the market closes on Thursday, February 10, 2022. A webcast and conference call will be held on Friday, February 11, 2022 at 11:00 a.m. Eastern Time to review the Company’s fiscal third quarter results, discuss recent events, and conduct a question-and-answer session. The live webcast and archived replay of the conference call can be accessed on the Investors section of the Company’s website at www.algoma.com. For those unable to access the webcast, the conference call will be accessible domestically or internationally by dialing...

Increases backlog to $105 million; Announces new products and forges new partnerships to meet growing demand for AI-enabled intelligent enterprise robotic solutions that transform supply chain operations BEDFORD, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) — Berkshire Grey Inc. (Nasdaq: BGRY), a leader in AI-enabled robotic solutions that automate supply chain processes, announced today it has recently secured $14 million in new orders since November 2021. These new orders include $8 million of orders from new customers and $6 million of follow-on new orders from the Company’s anchor accounts. The additional orders reflect growing demand from market-leading retailers, eCommerce providers, package handling companies and third-party logistics companies that rely on Berkshire Grey’s AI-enabled robotic solutions to automate and transform...

– Outcomes of first eight compassionate use cases presented at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society – – HAV observed to maintain patency and resist infection in the treatment of critical limb ischemia, infection and vascular trauma – – All patients lacked suitable alternative conduit options – DURHAM, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced results from the first series of compassionate use cases of Humacyte’s investigational Human Acellular Vessel (HAV) for the treatment of critical limb ischemia and vascular trauma. The HAVs were observed to remain patent and infection free in patients requiring vascular reconstruction,...

WASHINGTON, Jan. 31, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced continued investment in the firm’s Cybersecurity practice with the appointment of Todd Renner as a Senior Managing Director. Mr. Renner, who is based in Atlanta, spent the past two decades with the Federal Bureau of Investigation (“FBI”), where he led complex cybersecurity investigations across the globe and established relationships with domestic and international intelligence agencies, helping mitigate emerging cyber risks on the world’s stage. Most recently, Mr. Renner served as a Supervisory Special Agent in the Atlanta field office leading a team of investigators focused on pursuing financially motivated cyber criminals and nation-state actors posing a threat to national security. This included identifying cybersecurity vulnerabilities...